While current evidence is encouraging, more extensive and longer-term studies are needed to establish optimal dosing, treatment duration, and identify which subsets of individuals are most likely to benefit
Increasing systemic levels of L-Arginine has been demonstrated to significantly improve endothelial function in individuals with essential hypertension, compromised flow-mediated dilation, arterial stiffness, chronic heart failure, impaired glucose tolerance, and type 2 diabetes-all of which are common concomitant medical conditions associated with Erectile Dysfunction (ED).
Individuals with certain medical conditions, such as liver disease or kidney problems, should avoid these injections
26, 27 Primary antibodies included anti-phospho-p65 antibody (Cell signaling #3033, 1:1000), anti-p65 antibody (Cell Signaling #6956, 1:1000), anti-IB antibody (Cell Signaling #3033, 1:1000), anti-IB antibody (Cell Signaling #9242, 1:1000), anti-phospho- IB antibody (Cell Signaling #6956, 1:2859) and anti--tubulin (Sigma-Aldrich #T-9026, 1:5000)